Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
MWYN vs MLKN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
MLKN Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)
MLKN Overall Winner
6-Pillar Tally: MWYN 0 – 6 MLKN
Matrix Metrics: MWYN 2 – 8 MLKN
As of Nov 20, 2026, MillerKnoll, Inc. (MLKN) is the stronger overall head-to-head candidate over Marwynn Holdings, Inc. (MWYN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MWYN carries a Unified Composite Score of 50.0/100 (HOLD) at $1.19 (N/M Forward P/E, -13.8% operating margin), whereas MLKN carries 46.3/100 (HOLD) at $19.82 (9.9x Forward P/E, 5.7% operating margin).
- Composite vs. Pillar Nuance: While MWYN currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. MLKN 46.3/100 HOLD), MLKN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (5.7% vs. -13.8% operating margin) and revenue trajectory (-3.4% vs. +2543.5% YoY).
- Technical & Structure Timing Caution: MWYN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 40.5); meanwhile MLKN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About MWYN vs MLKN
MWYN
Marwynn Holdings, Inc. Common stock
$1.19
-4.8% 1D
Market Cap
$30.2M
TTM Revenue
$5.3M
Forward P/E
N/M
Beta / 30D Vol
-1.40β · 180% Vol
Unified Composite Score
50.0
HOLD
Tech 60.0
Fund 54.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
MLKN
Head-to-Head Winner
MillerKnoll, Inc. Common Stock
$19.82
-1.69% 1D
Market Cap
$1.4B
TTM Revenue
$3.81B
Forward P/E
9.9x
Beta / 30D Vol
1.21β · 47% Vol
Unified Composite Score
46.3
HOLD
Tech 38.0
Fund 50.0
Flow 64.0
Mom 50.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (MWYN 0 – 6 MLKN)
1. Valuation Multiples
MLKN
Forward P/E
N/M
9.9x
Trailing P/E
N/M
14.3x
PEG Ratio
N/M
0.87x
EV / Revenue
5.7x
0.8x
2. Growth & Scale
MLKN
Revenue Growth (YoY)
+2543.5%
-3.4%
Earnings Growth (YoY)
-91.9%
+31.0%
TTM Revenue (USD)
$5.3M
$3.81B
Market Cap
$30.2M
$1.4B
3. Profitability & Quality
MLKN
Gross Margin
16.0%
39.6%
Operating Margin
-13.8%
5.7%
Net Profit Margin
-24.7%
2.6%
Return on Equity (ROE)
-31.1%
7.3%
4. Balance Sheet & Cash Flow
MLKN
Cash Generation (TTM)
-$1.5M
$116M
Cash Flow Margin
-29.2%
3.0%
Net Cash / Leverage
-$140,463 Net Debt (0.00x D/E)
$1.64B Net Debt (1.34x D/E)
Dividend Yield
None (0.00%)
3.61%
5. Options & Positioning
MLKN
Options Structure Phase
UNCLASSIFIED
CONSOLIDATION
Current IV / %ile
N/A (N/A)
86.9% (10th %ile)
Put/Call OI Skew
N/A
1.46x (Put-Skewed)
OBV Trend / Tech Phase
NEUTRAL · Neutral
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
MLKN
OpEx & R&D Intensity
29.8% of Rev ($1.6M)
33.9% of Rev ($1.29B)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Furnishings, Fixtures & Appliances Operator
Furnishings, Fixtures & Appliances Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: MWYN (2) vs MLKN (8)| Institutional Metric | MWYN | MLKN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $30.2M | $1.4B | MLKN | |
| Trailing P/E Ratio | N/M | 14.3x | MLKN | |
| Forward P/E Ratio | N/M | 9.9x | MLKN | |
| Revenue Growth (YoY) | +2543.5% | -3.4% | MWYN | |
| Operating Margin (TTM) | -13.8% | 5.7% | MLKN | |
| Net Profit Margin | -24.7% | 2.6% | MLKN | |
| Return on Equity (ROE) | -31.1% | 7.3% | MLKN | |
| 52-Week Range Position | 31% ($0–$3) | 55% ($14–$25) | MLKN | |
| Beta / 30D Volatility | -1.40β · 180% Vol | 1.21β · 47% Vol | MLKN | |
| Unified Institutional Score | 50.0 / 100 (HOLD) | 46.3 / 100 (HOLD) | MWYN | |
| Trailing 12M Revenue (USD) | $5.3M | $3.81B | Scale | |
| Gross Profit Margin (TTM) | 16.0% | 39.6% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 5.7x EV/Rev | 0.87x PEG · 0.8x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$1.5M (-$140,463 Net Debt (0.00x D/E)) | $116M ($1.64B Net Debt (1.34x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
MLKN +38.06 pp
3M Horizon
MWYN +27.75 pp
6M Horizon
MWYN +6.81 pp
1Y Horizon
MLKN +1.43 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MWYN Revenue | MLKN Revenue | MWYN Op. Margin | MLKN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2019 | N/A | $2.57B | N/A | 7.9% | MLKN |
| FY2020 | N/A | $2.49B | N/A | -1.5% | MLKN |
| FY2021 | N/A | $2.47B | N/A | 9.4% | MLKN |
| FY2022 | N/A | $3.95B | N/A | 1.0% | MLKN |
| FY2023 | N/A | $4.09B | N/A | 3.0% | MLKN |
| FY2024 | $10M | $3.63B | 11.7% | 4.6% | MWYN |
| FY2025 | $0M | $3.67B | -541.3% | 1.4% | MLKN |
| FY2026 | $0M | $3.84B | -77.3% | 5.2% | MLKN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
MWYN
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact MWYN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
MLKN
CONSOLIDATION
Current IV
86.9%
IV Percentile
10th %ile
Put/Call OI Skew
1.46x (Put-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact MLKN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
MWYN Moat Profile
Cyclical / Execution-Driven Positioning
Furnishings, Fixtures & Appliances Operator
OpEx & R&D Reinvestment
29.8% of Rev ($1.6M)
90D Engineering Disclosures
0 Published
MLKN Moat Profile
Cyclical / Execution-Driven Positioning
Furnishings, Fixtures & Appliances Operator
OpEx & R&D Reinvestment
33.9% of Rev ($1.29B)
90D Engineering Disclosures
0 Published
Investor FAQ MWYN vs MLKN Key Questions & Quantitative Answers
As of Nov 20, 2026, MillerKnoll, Inc. (MLKN) is the stronger overall head-to-head candidate over Marwynn Holdings, Inc. (MWYN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MWYN carries a Unified Composite Score of 50.0/100 (HOLD) at $1.19 (N/M Forward P/E, -13.8% operating margin), whereas MLKN carries 46.3/100 (HOLD) at $19.82 (9.9x Forward P/E, 5.7% operating margin). Composite vs. Pillar Nuance: While MWYN currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. MLKN 46.3/100 HOLD), MLKN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (5.7% vs. -13.8% operating margin) and revenue trajectory (-3.4% vs. +2543.5% YoY). Technical & Structure Timing Caution: MWYN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 40.5); meanwhile MLKN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MLKN leads the Growth & Scale pillar: MWYN posts +2543.5% YoY revenue growth and -91.9% YoY earnings growth on $5.3M TTM revenue (16.0% gross margin, -13.8% operating margin), compared with MLKN at -3.4% YoY revenue growth and +31.0% YoY earnings growth on $3.81B TTM revenue (39.6% gross margin, 5.7% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), MWYN cumulative revenue shifted N/A while MLKN shifted +49.4%. In operating R&D and SG&A reinvestment, MWYN deploys 29.8% of Rev ($1.6M) (0 90-day corporate R&D disclosures) versus 33.9% of Rev ($1.29B) (0 disclosures) for MLKN.
MLKN screens cheaper on headline valuation multiples. MWYN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 5.7x EV/Revenue (-29.2% FCF margin), whereas MLKN trades at 9.9x Forward P/E, 14.3x Trailing P/E, 0.87x PEG, and 0.8x EV/Revenue (3.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MWYN (-31.1% ROE) versus MLKN (7.3% ROE) capital efficiency.
In options market volatility and institutional positioning, MWYN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.40β · 180% Vol realized risk). By comparison, MLKN carries 86.9% implied volatility (10th %ile, Compressed (<25th %ile)), a 1.46x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.21β · 47% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
MLKN vs MWYN · Reverse Pair
MWYN vs EDHL
· Sector Peer
MLKN vs EPAC
· Sector Peer
MLKN vs ETD
· Sector Peer
MLKN vs WLY
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma